DUSA Pharmaceuticals, Inc.®, is pleased to announce that the Korea Food and Drug Administration has approved Levulan® Kerastick® for Photodynamic Therapy for the treatment of actinic keratoses through its marketing partner Daewoong Pharmaceutical Co., Ltd and its affiliate, DNC Daewoong Derma & Plastic Surgery Network Company.
From: biz.yahoo.com
R) Receives Marketing Approval in Korea
Posted by Ruslan Abuzant at 6:03 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment